Cognition Therapeutics, Inc. (CGTX) Misses Q3 EPS by 5c

Cognition Therapeutics, Inc. (NASDAQ: CGTX) reported Q3 EPS of ($0.25), $0.05 worse than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Cognition Therapeutics, Inc. (CGTX) click here.

You May Also Be Interested In

• Dell (DELL) PT Raised to $505 at BofA Securities
• Baird Upgrades Titan Machinery (TITN) to Outperform
• Mizuho Starts Air Liquid SA (AI:FP) (AIQUY) at Outperform